SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-005640
Filing Date
2019-08-01
Accepted
2019-08-01 17:16:08
Documents
8
Period of Report
2019-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_080119.htm 8-K 31716
2 UNDERWRITING AGREEMENT ex1-1.htm EX-1.1 235259
3 FORM OF WARRANT ex4-1.htm EX-4.1 143089
4 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN ex5-1.htm EX-5.1 9656
5 PRESS RELEASE DATED JULY 31, 2019 ex99-1.htm EX-99.1 9390
6 PRESS RELEASE DATED AUGUST 1, 2019 ex99-2.htm EX-99.2 12371
7 GRAPHIC admp8k001.jpg GRAPHIC 16128
8 GRAPHIC admp8k002.jpg GRAPHIC 16149
  Complete submission text file 0001387131-19-005640.txt   487471
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 19993603
SIC: 2834 Pharmaceutical Preparations